ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49209
0.00%
Bitcoin
66,972.23
-0.17%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Cabaletta Bio Inc (CABA)

  7. Cabaletta Bio Inc (CABA) News

CABA

Cabaletta Bio (CABA)

Cabaletta Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CABA
DateTimeSourceHeadlineSymbolCompany
15/05/202421:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CABACabaletta Bio Inc
15/05/202421:04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
15/05/202421:00GlobeNewswire Inc.Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
13/05/202422:00GlobeNewswire Inc.Cabaletta Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQNASDAQ:CABACabaletta Bio Inc
21/03/202422:00GlobeNewswire Inc.Cabaletta Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
20/03/202422:00GlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
05/03/202409:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
05/03/202409:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
05/03/202409:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
05/03/202409:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
05/03/202409:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
28/02/202400:00GlobeNewswire Inc.Cabaletta Bio to Participate in Upcoming Investor Conferences in MarchNASDAQ:CABACabaletta Bio Inc
15/02/202401:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CABACabaletta Bio Inc
14/02/202410:47Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CABACabaletta Bio Inc
02/02/202408:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
02/02/202408:30GlobeNewswire Inc.Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of MyositisNASDAQ:CABACabaletta Bio Inc
01/02/202400:00GlobeNewswire Inc.Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:CABACabaletta Bio Inc
20/01/202410:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
08/01/202423:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
08/01/202423:00GlobeNewswire Inc.Cabaletta Bio Receives Additional FDA Fast Track Designations for CABA-201 in Dermatomyositis and Systemic SclerosisNASDAQ:CABACabaletta Bio Inc
03/01/202400:00GlobeNewswire Inc.Cabaletta Bio to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:CABACabaletta Bio Inc
20/12/202312:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
29/11/202322:18IH Market NewsAmazon Unveils Innovative Services, Okta Discloses Data Breach, Textron Plans 2% Global Workforce Reduction, and MoreNASDAQ:CABACabaletta Bio Inc
29/11/202308:30GlobeNewswire Inc.Cabaletta Bio to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:CABACabaletta Bio Inc
29/11/202306:59Dow Jones NewsCabaletta Bio Down as FDA Looks Into Issues With Several Companies' Approved CAR T DrugsNASDAQ:CABACabaletta Bio Inc
22/11/202308:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CABACabaletta Bio Inc
21/11/202308:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CABACabaletta Bio Inc
09/11/202323:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CABACabaletta Bio Inc
09/11/202323:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CABACabaletta Bio Inc
09/11/202323:00GlobeNewswire Inc.Cabaletta Bio Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CABACabaletta Bio Inc
 Showing the most relevant articles for your search:NASDAQ:CABA

Your Recent History

LSE
0FP0
Prim
LSE
56SP
Bskyb 26
USOTC
LFIN
LongFin (CE)
BIT
UB48GS
Unicredit Bank
LSE
70TM
Elenia Ver. 29
GATE
KMONUSDT
KmonCoin
BMF
DOLF29
DOLF29 - Janeiro 2029
POLO
BOTSUSDT
Deezbots
LATK
LBCUSDT
Legacy Builder Coin
COIN
KISHIMOTOUST
Kishimoto Inu
EU
W798S
W798S
LSE
LE70
Barclays 28
BTRX
ARTICUSDT
ARTIC
BIT
UC8MRK
Unicredit Bank
USOTC
PPKTF
PT Pabrik Kertas Tjiwi K... (PK)
USOTC
PTEO
Proteo (GM)
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved